Sibel Health, a leader in wearable biosensing and digital health, today announced that it has been awarded a competitive ...

YaoPharma will complete the ongoing Phase 1 study before handing development rights to Pfizer. ・YaoPharma will receive a $150 ...

The FDA has cleared the first artificial intelligence (AI) drug development tool to help evaluate fatty liver disease in ...

The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a ...

I use the word 'trial' but, let's be honest, this is an experiment. A state-sanctioned exercise which, no matter how it is ...

An infant botulism outbreak has sickened at least 39 babies across the U.S. and underscored the crucial role of a medication ...

Pfizer Inc. has entered into an exclusive global collaboration and licensing deal with a unit of Shanghai Fosun ...

An industry-focused, end-to-end meeting covering neurodegenerative R&D from early discovery through late-stage clinical and ...

The status could support staged transitions to new manufacturing processes, potentially mitigating some risks of high-stakes ...

Big American drugmakers are hunting for novel weight loss drugs in the labs of China’s biotech industry, while U.S.

SHELTON, CT, December 9, 2025 (EZ Newswire) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”) today reported that ...

Pfizer (PFE) is reiterated as a Buy, supported by the world's largest drug pipeline and trading below intrinsic value, ...